Conference item

Quality of life in patients with advanced NSCLC treated in second- or third-line with nab-paclitaxel + durvalumab: abound.2l+

Publication status:: Published

Peer review status:: Reviewed (other)

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Talbot, D., Govindan, R., Cobo, M., Ponce Aix, S., Postmus, P. E., Lewanski, C., Bennouna, J., Fischer, J., Juan-Vidal, O., Stewart, D., Ardizzoni, A., Bhore, R., Wolfsteiner, M., Reck, M., Morgensztern, D., & Ong, T. J. (2018). Quality of life in patients with advanced NSCLC treated in second- or third-line with nab-paclitaxel + durvalumab: abound.2l+. Journal of Thoracic Oncology, 13(10), S498–S499.

MLA Style

Talbot, D., et al. “Quality of Life in Patients with Advanced NSCLC Treated in Second- or Third-Line with Nab-Paclitaxel + Durvalumab: Abound.2l+.” Journal of Thoracic Oncology, vol. 13, no. 10, Elsevier, 2018, pp. S498–S499.

Chicago Style

Talbot, D, R Govindan, M Cobo, S Ponce Aix, PE Postmus, C Lewanski, J Bennouna, et al. 2018. “Quality of Life in Patients with Advanced NSCLC Treated in Second- or Third-Line with Nab-Paclitaxel + Durvalumab: Abound.2l+.” In Journal of Thoracic Oncology, 13:S498–S499. Elsevier.
Share
Print

Access Document

Files:: Talbot.pdf

(Preview, Version of record, 192.0KB, Terms of use)

Publisher copy:: 10.1016/j.jtho.2018.08.649

Authors

+ Talbot, D More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Oncology
Role:: Author
ORCID:: 0000-0002-0183-0642

+ Govindan, R More by this author

Role:: Author

+ Cobo, M More by this author

Role:: Author

+ Ponce Aix, S More by this author

Role:: Author

+ Postmus, PE More by this author

Role:: Author

More authors...

Publisher:: Elsevier
Host title:: Journal of Thoracic Oncology
Journal:: Journal of Thoracic Oncology More from this journal
Volume:: 13
Issue:: 10
Pages:: S498-S499
Publication date:: 2018-10-22
DOI:: 10.1016/j.jtho.2018.08.649
EISSN:: 1556-1380
ISSN:: 1556-0864

Language:: English
Keywords:: quality of life

nab-paclitaxel

durvalumab

FFR
Pubs id:: 958269
Local pid:: pubs:958269
Deposit date:: 2020-06-08

Terms of use

Copyright holder:: Elsevier Inc.
Copyright date:: 2018
Rights statement:: Copyright © 2018 Published by Elsevier Inc. This is an open access article published under CC BY 4.0.

Licence:: CC Attribution (CC BY)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP